Baxter (NYSE: BAX) reported Q1 EPS of $0.76, $0.08 better than the analyst estimate of $0.68. Revenue for the quarter came in at $2.63 billion versus the consensus estimate of $2.61 billion.

GUIDANCE:

Baxter sees Q2 2019 EPS of $0.80-$0.82, versus the consensus of $0.82.

• For second-quarter 2019: The company expects sales to decline approximately 2 percent on a reported basis, and to grow approximately 2 percent on a constant currency basis and 2 to 3 percent on an operational basis.

Baxter sees FY2019 EPS of $3.27-$3.35, versus the consensus of $3.28.

• The company continues to expect sales growth of 0 to 1 percent on a reported basis, 2 to 3 percent on a constant currency basis and 3 to 4 percent on an operational basis.

For earnings history and earnings-related data on Baxter (BAX) click here.